A Practical Look at Cardiorenal Protection for CKD in T2D: Applying Recent Data
Host: Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
\n\n Guest: Maria Luiza Caramori, MD, PhD, MSc
\n\n Guest: Ana Maria Cebri\xe1n-Cuenca, MD, PhD
\n\n Guest: Pam R. Taub, MD, FACC, FASPC
\n\n\n \n
Optimal treatment with guideline-directed therapies, including RAS inhibitors, SGLT2 inhibitors, and nonsteroidal MRAs, is paramount in preventing progressive renal dysfunction and cardiorenal events in patients with chronic kidney disease and type 2 diabetes. As the patient becomes more complex, a multidisciplinary approach is often necessary to improve their outcomes. Listen in as our panel of experts offers strategies to improve collaboration and patient care.